Table 3.
Neostigmine (n = 47) | Sugammadex (n = 46) | RD (95% CI) | P value | |
---|---|---|---|---|
Incidence of PPCs | 19 (40.4) | 15 (32.6) | 0.08 (−0.12, 0.27) | 0.434 |
Prolonged air leakage | 5 (10.6) | 2 (4.3) | 0.06 (−0.04, 0.17) | 0.435 |
Pneumonia | 2 (4.3) | 1 (2.2) | 0.02 (−0.05, 0.09) | 1.000 |
Atelectasis | 14 (29.8) | 8 (17.4) | 0.12 (−0.05, 0.29) | 0.160 |
Desaturation | 5 (10.6) | 6 (15.0) | –0.07 (−0.21, 0.07) | 0.348 |
Reintubation | 1 (2.1) | 0 (0.0) | 0.02 (−0.02, 0.06) | 1.000 |
Number of complications per patient (1/2/3) | 13/4/2 | 11/4/0 | 0.379 | |
Atrial fibrillation | 3 (6.4) | 1 (2.2) | 0.04 (−0.04, 0.12) | 0.617 |
PTE | 5 (10.6) | 1 (2.2) | 0.08 (−0.01, 0.18) | 0.203 |
Values are presented as number (%) or number only. RD: risk difference, 95% CI: 95% confidence interval, PPCs: postoperative pulmonary complications, PTE: pulmonary thromboembolism.